Quadrant Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$3.46M Buy
30,517
+90
+0.3% +$9.88K 1.57% 22
2019
Q3
$3.31M Sell
30,427
-2,429
-7% -$253K 1.62% 19
2019
Q2
$3.2M Buy
32,856
+355
+1% +$32.4K 1.68% 19
2019
Q1
$2.96M Sell
32,501
-129
-0.4% -$11.5K 1.64% 23
2018
Q4
$2.97M Sell
32,630
-325
-1% -$30.4K 1.95% 15
2018
Q3
$3.24M Buy
32,955
+55
+0.2% +$5.08K 2.06% 16
2018
Q2
$2.82M Sell
32,900
-550
-2% -$45.9K 2% 21
2018
Q1
$2.68M Sell
33,450
-375
-1% -$30.9K 1.97% 21
2017
Q4
$2.73M Buy
33,825
+300
+0.9% +$24K 1.92% 22
2017
Q3
$1.69M Buy
33,525
+939
+3% +$78K 1.24% 38
2017
Q2
$2.89M Sell
32,586
-147
-0.4% -$12.4K 2.26% 14
2017
Q1
$2.64M Buy
32,733
+7,530
+30% +$588K 2.13% 18
2016
Q4
$1.79M Sell
25,203
-7,982
-24% -$627K 1.54% 34
2016
Q3
$2.87M Sell
33,185
-190
-0.6% -$16.6K 2.42% 11
2016
Q2
$2.9M Sell
33,375
-697
-2% -$56.4K 2.44% 9
2016
Q1
$2.56M Buy
34,072
+302
+0.9% +$22.7K 2.18% 15
2015
Q4
$2.6M Buy
33,770
+1,360
+4% +$102K 2.11% 13
2015
Q3
$2.17M Buy
+32,410
New +$2.39M 1.84% 22

Other funds holding MDT

Quadrant Capital Management's MDT Position: Q4 2019 in Review

Quadrant Capital Management increased its Medtronic (MDT) stake by 0.3% in Q4 2019, buying an estimated $9.88K and bringing the position to 30,517 shares worth $3.46M. The position accounts for 1.57% of the portfolio, ranked #22.

Quadrant Capital Management first reported a position in MDT in Q3 2015 and has held it in 18 quarters since. 1,820 funds tracked by Wall St. Rank hold MDT as of Q4 2019.

  • Quadrant Capital Management held 30,517 shares of Medtronic worth $3.46M as of Q4 2019.
  • Quadrant Capital Management bought 90 Medtronic shares in Q4 2019, an estimated $9.88K.
  • Medtronic made up 1.57% of Quadrant Capital Management's portfolio in Q4 2019, its #22 holding.
  • Quadrant Capital Management first reported a position in Medtronic in Q3 2015 and has held it in 18 quarters since.
  • 1,820 funds tracked by Wall St. Rank held Medtronic as of Q4 2019.

Based on Quadrant Capital Management's 13F filing for Q4 2019, filed 29 Jan 2020.